Philip Hemme

Fresh after leading Calliditas Therapeutics through a $1.1B acquisition, Renee Aguiar-Lucander takes us through her new CEO role at Hansa Biopharma �...

We’re with Stephane Bancel, CEO of the US mRNA giant Moderna. The company’s 15-year trajectory has taken it from the startup seed stage to a comm...

We’re online with Chris Martin, COO of the 6th most valuable biotech in Europe, Verona Pharma. Their amazing story sees them bring a fully...

The biotech industry in Europe is booming, with companies making groundbreaking medical advances, from oncology and gene therapy to immunology and rar...

We’re online with Daniela Marino, CEO and co-founder of one of the best companies in Europe for tissue therapeutics, CUTISS. We discussed the stor...

We’re in Barcelona 🇪🇸  with Joris Pezzini from Alira Health to discuss the hottest biotech insights right now, including obesity, I&I, ...

We’re in Copenhagen 🇩🇰 with Christophe Bourdon, the CEO who turned a 116-year-old biopharma company from the brink of failure to suc...

We’re in Munich 🇩🇪 with Cristoph Broja, Partner at EQT Life Sciences, the top venture capital firm in Europe. We talk about his lessons up u...

We’re in Munich with Philipp Baaske, one of the best life science tools founder in Europe. We talked about the lessons building this life ...

We’re online 🇸🇪 with Mathias Uhlen, one of the best entrepreneurial scientists in Europe. We talked about the entrepreneurial mindset in aca...